Producing cell and gene therapies is exceptionally complex, and the stakes are incredibly high. For the contract development and manufacturing organizations (CDMOs) enabling these treatments, operational efficiency isn’t just about saving time and money; it can be a matter of life and death.
Recognizing this, an industry-leading CDMO modernized its scientific data strategy for developing and analyzing cell and gene therapies. Initially, its scientists relied on paper-based records and spreadsheets to track and record data. These methods were slow and prone to human error.
The CDMO decided to implement an integrated solution combining LabVantage LIMS with the Tetra Scientific Data and AI Cloud™. The solution led to several key outcomes:
- Higher productivity for scientists
- Improved data integrity
- Future-proof, AI-ready data
